Advertisement
Review| Volume 79, ISSUE 3, P243-250, February 01, 2016

Intranasal Oxytocin: Myths and Delusions

      Abstract

      Despite widespread reports that intranasal application of oxytocin has a variety of behavioral effects, very little of the huge amounts applied intranasally appears to reach the cerebrospinal fluid. However, peripheral concentrations are increased to supraphysiologic levels, with likely effects on diverse targets including the gastrointestinal tract, heart, and reproductive tract. The wish to believe in the effectiveness of intranasal oxytocin appears to be widespread and needs to be guarded against with scepticism and rigor. Preregistering trials, declaring primary and secondary outcomes in advance, specifying the statistical methods to be applied, and making all data openly available should minimize problems of publication bias and questionable post hoc analyses. Effects of intranasal oxytocin also need proper dose-response studies, and such studies need to include control subjects for peripheral effects, by administering oxytocin peripherally and by blocking peripheral actions with antagonists. Reports in the literature of oxytocin measurements include many that have been made with discredited methodology. Claims that peripheral measurements of oxytocin reflect central release are questionable at best.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Leng G.
        • Ludwig M.
        Neurotransmitters and peptides: Whispered secrets and public announcements.
        J Physiol. 2008; 586: 5625-5632
        • Ludwig M.
        • Leng G.
        Dendritic peptide release and peptide-dependent behaviours.
        Nat Rev Neurosci. 2006; 7: 126-136
        • Kendrick K.M.
        • Keverne E.B.
        • Baldwin B.A.
        Intracerebroventricular oxytocin stimulates maternal behaviour in the sheep.
        Neuroendocrinology. 1987; 46: 56-61
        • Pedersen C.A.
        • Ascher J.A.
        • Monroe Y.L.
        • Prange Jr., A.J.
        Oxytocin induces maternal behavior in virgin female rats.
        Science. 1982; 216: 648-650
        • Williams J.R.
        • Insel T.R.
        • Harbaugh C.R.
        • Carter C.S.
        Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster).
        J Neuroendocrinol. 1994; 6: 247-250
        • Green J.J.
        • Hollander E.
        Autism and oxytocin: New developments in translational approaches to therapeutics.
        Neurotherapeutics. 2010; 7: 250-257
        • Fabian M.
        • Forsling M.L.
        • Jones J.J.
        • Lee J.
        The release, clearance and plasma protein binding of oxytocin in the anaesthetized rat.
        J Endocrinol. 1969; 43: 175-189
        • Morin V.
        • Del Castillo J.R.
        • Authier S.
        • Ybarra N.
        • Otis C.
        • Gauvin D.
        • et al.
        Evidence for non-linear pharmacokinetics of oxytocin in anesthetizetized rat.
        J Pharm Pharm Sci. 2008; 11: 12-24
        • Jones P.M.
        • Robinson I.C.
        Differential clearance of neurophysin and neurohypophysial peptides from the cerebrospinal fluid in conscious guinea pigs.
        Neuroendocrinology. 1982; 34: 297-302
        • Mens W.B.
        • Witter A.
        • van Wimersma Greidanus T.B.
        Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF.
        Brain Res. 1983; 262: 143-149
        • Brinker T.
        • Stopa E.
        • Morrison J.
        • Klinge P.
        A new look at cerebrospinal fluid circulation.
        Fluids Barriers CNS. 2014; 11: 10
        • Durham D.A.
        • Banks W.A.
        • Kastin A.J.
        Carrier-mediated transport of labeled oxytocin from brain to blood.
        Neuroendocrinology. 1991; 53: 447-452
        • Heller H.
        • Zaimis E.J.
        The antidiuretic and oxytocic hormones in the posterior pituitary glands of newborn infants and adults.
        J Physiol. 1949; 109: 162-169
        • De Groot A.N.
        • Vree T.B.
        • Hekster Y.A.
        • Pesman G.J.
        • Sweep F.C.
        • Van Dongen P.J.
        • et al.
        Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers.
        J Pharm Pharmacol. 1995; 47: 571-575
        • Amico J.A.
        • Ulbrecht J.S.
        • Robinson A.G.
        Clearance studies of oxytocin in humans using radioimmunoassay measurements of the hormone in plasma and urine.
        J Clin Endocrinol Metab. 1987; 64: 340-345
        • Ermisch A.
        • Barth T.
        • Ruhle H.J.
        • Skopkova J.
        • Hrbas P.
        • Landgraf R.
        On the blood-brain barrier to peptides: Accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions.
        Endocrinol Exp. 1985; 19: 29-37
        • Born J.
        • Lange T.
        • Kern W.
        • McGregor G.P.
        • Bickel U.
        • Fehm H.L.
        Sniffing neuropeptides: A transnasal approach to the human brain.
        Nat Neurosci. 2002; 5: 514-516
        • Abbott N.J.
        • Patabendige A.A.
        • Dolman D.E.
        • Yusof S.R.
        • Begley D.J.
        Structure and function of the blood-brain barrier.
        Neurobiol Dis. 2010; 37: 13-25
        • Ang V.T.
        • Jenkins J.S.
        Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog.
        J Endocrinol. 1982; 93: 319-325
        • Striepens N.
        • Kendrick K.M.
        • Hanking V.
        • Landgraf R.
        • Wullner U.
        • Maier W.
        • et al.
        Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans.
        Sci Rep. 2013; 3: 3440
        • Scheele D.
        • Wille A.
        • Kendrick K.M.
        • Stoffel-Wagner B.
        • Becker B.
        • Gunturkun O.
        • et al.
        Oxytocin enhances brain reward system responses in men viewing the face of their female partner.
        Proc Natl Acad Sci U S A. 2013; 110: 20308-20313
        • Neumann I.D.
        • Maloumby R.
        • Beiderbeck D.I.
        • Lukas M.
        • Landgraf R.
        Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice.
        Psychoneuroendocrinology. 2013; 38: 1985-1993
        • Dal Monte O.
        • Noble P.L.
        • Turchi J.
        • Cummins A.
        • Averbeck B.B.
        CSF and blood oxytocin concentration changes following intranasal delivery in macaque.
        PloS One. 2014; 9: e103677
        • Chang S.W.
        • Barter J.W.
        • Ebitz R.B.
        • Watson K.K.
        • Platt M.L.
        Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta).
        Proc Natl Acad Sci U S A. 2012; 109: 959-964
        • Modi M.E.
        • Connor-Stroud F.
        • Landgraf R.
        • Young L.J.
        • Parr L.A.
        Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.
        Psychoneuroendocrinology. 2014; 45: 49-57
        • Russell J.A.
        • Leng G.
        • Douglas A.J.
        The magnocellular oxytocin system, the fount of maternity: Adaptations in pregnancy.
        Front Neuroendocrinol. 2003; 24: 27-61
        • Conti F.
        • Sertic S.
        • Reversi A.
        • Chini B.
        Intracellular trafficking of the human oxytocin receptor: Evidence of receptor recycling via a Rab4/Rab5 “short cycle.”.
        Am J Physiol Endocrinol Metabol. 2009; 296: E532-E542
        • Ludwig M.
        • Tobin V.A.
        • Callahan M.F.
        • Papadaki E.
        • Becker A.
        • Engelmann M.
        • et al.
        Intranasal application of vasopressin fails to elicit changes in brain immediate early gene expression, neural activity and behavioural performance of rats.
        J Neuroendocrinol. 2013; 25: 655-667
        • Maejima Y.
        • Rita R.S.
        • Santoso P.
        • Aoyama M.
        • Hiraoka Y.
        • Nishimori K.
        • et al.
        Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas.
        Neuroendocrinology. 2015; 101: 35-44
        • Kimura T.
        • Saji F.
        • Nishimori K.
        • Ogita K.
        • Nakamura H.
        • Koyama M.
        • et al.
        Molecular regulation of the oxytocin receptor in peripheral organs.
        J Mol Endocrinol. 2003; 30: 109-115
        • Hoover R.T.
        Intranasal oxytocin in eighteen hundred patients. A study on its safety as used in a community hospital.
        Am J Obstet Gynecol. 1971; 110: 788-794
        • Hendricks C.H.
        • Gabel R.A.
        Use of intranasal oxytocin in obstetrics. 1. A laboratory evaluation.
        Am J Obstet Gynecol. 1960; 79: 780-788
        • Robertson G.L.
        • Klein L.A.
        • Roth J.
        • Gorden P.
        Immunoassay of plasma vasopressin in man.
        Proc Natl Acad Sci U S A. 1970; 66: 1298-1305
        • Chaves V.E.
        • Tilelli C.Q.
        • Brito N.A.
        • Brito M.N.
        Role of oxytocin in energy metabolism.
        Peptides. 2013; 45: 9-14
        • Leng G.
        • Onaka T.
        • Caquineau C.
        • Sabatier N.
        • Tobin V.A.
        • Takayanagi Y.
        Oxytocin and appetite.
        Prog Brain Res. 2008; 170: 137-151
        • Iwasaki Y.
        • Maejima Y.
        • Suyama S.
        • Yoshida M.
        • Arai T.
        • Katsurada K.
        • et al.
        Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: A route for ameliorating hyperphagia and obesity.
        Am J Physiol Regul Integr Comp Physiol. 2014; 308: R360-R369
        • Altszuler N.
        • Hampshire J.
        Intranasal instillation of oxytocin increases insulin and glucagon secretion.
        Proc Soc Exp Med. 1981; 168: 123-124
        • Roh S.G.
        • Koiwa K.
        • Sato K.
        • Ohtani Y.
        • Takahashi T.
        • Katoh K.
        Actions of intravenous injections of AVP and oxytocin on plasma ACTH, GH, insulin and glucagon concentrations in goats.
        Anim Sci J. 2014; 85: 286-292
        • Stock S.
        • Uvnas-Moberg K.
        Oxytocin infusions increase plasma levels of insulin and VIP but not of gastrin in conscious dogs.
        Acta Physiol Scand. 1985; 125: 205-210
        • Suzuki M.
        • Honda Y.
        • Li M.Z.
        • Masuko S.
        • Murata Y.
        The localization of oxytocin receptors in the islets of Langerhans in the rat pancreas.
        Regul Pep. 2013; 183: 42-45
        • Fujiwara Y.
        • Hiroyama M.
        • Sanbe A.
        • Yamauchi J.
        • Tsujimoto G.
        • Tanoue A.
        Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
        J Endocrinol. 2007; 192: 361-369
        • Richard P.
        • Moos F.
        • Freund-Mercier M.J.
        Central effects of oxytocin.
        Physiol Rev. 1991; 71: 331-370
        • Daniels D.
        • Flanagan-Cato L.M.
        Functionally-defined compartments of the lordosis neural circuit in the ventromedial hypothalamus in female rats.
        J Neurobiol. 2000; 45: 1-13
        • Argiolas A.
        • Melis M.R.
        Neuropeptides and central control of sexual behaviour from the past to the present: A review.
        Prog Neurobiol. 2013; 108: 80-107
        • Whittington K.
        • Assinder S.J.
        • Parkinson T.
        • Lapwood K.R.
        • Nicholson H.D.
        Function and localization of oxytocin receptors in the reproductive tissue of rams.
        Reproduction. 2001; 122: 317-325
        • Nicholson H.D.
        • Whittington K.
        Oxytocin and the human prostate in health and disease.
        Int Rev Cytol. 2007; 263: 253-286
        • Vignozzi L.
        • Filippi S.
        • Luconi M.
        • Morelli A.
        • Mancina R.
        • Marini M.
        • et al.
        Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility.
        Endocrinology. 2004; 145: 1823-1834
        • Gutkowska J.
        • Jankowski M.
        Oxytocin revisited: Its role in cardiovascular regulation.
        J Neuroendocrinol. 2012; 24: 599-608
        • Kemp A.H.
        • Quintana D.S.
        • Kuhnert R.L.
        • Griffiths K.
        • Hickie I.B.
        • Guastella A.J.
        Oxytocin increases heart rate variability in humans at rest: Implications for social approach-related motivation and capacity for social engagement.
        PloS One. 2012; 7: e44014
        • Gonzalez-Iglesias A.E.
        • Fletcher P.A.
        • Arias-Cristancho J.A.
        • Cristancho-Gordo R.
        • Helena C.V.
        • Bertram R.
        • et al.
        Direct stimulatory effects of oxytocin in female rat gonadotrophs and somatotrophs in vitro: Comparison with lactotrophs.
        Endocrinology. 2015; 156: 600-612
        • Page S.R.
        • Ang V.T.
        • Jackson R.
        • White A.
        • Nussey S.S.
        • Jenkins J.S.
        The effect of oxytocin infusion on adenohypophyseal function in man.
        Clin Endocrinol. 1990; 32: 307-313
        • Link H.
        • Dayanithi G.
        • Gratzl M.
        Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients.
        Endocrinology. 1993; 132: 873-878
        • Weisman O.
        • Zagoory-Sharon O.
        • Feldman R.
        Oxytocin administration alters HPA reactivity in the context of parent-infant interaction.
        Eur Neuropsychopharmacol. 2013; 23: 1724-1731
        • Colaianni G.
        • Sun L.
        • Zaidi M.
        • Zallone A.
        Oxytocin and bone.
        Am J Physiol Regul Integr Comp Physiol. 2014; 307: R970-R977
        • Geenen V.
        • Bodart G.
        • Henry S.
        • Michaux H.
        • Dardenne O.
        • Charlet-Renard C.
        • et al.
        Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity.
        Front Neurosci. 2013; 7: 187
        • Levasseur G.
        • Baly C.
        • Grebert D.
        • Durieux D.
        • Salesse R.
        • Caillol M.
        Anatomical and functional evidence for a role of arginine-vasopressin (AVP) in rat olfactory epithelium cells.
        Eur J Neurosci. 2004; 20: 658-670
        • Zhang G.
        • Zhang Y.
        • Fast D.M.
        • Lin Z.
        • Steenwyk R.
        Ultra sensitive quantitation of endogenous oxytocin in rat and human plasma using a two-dimensional liquid chromatography-tandem mass spectrometry assay.
        Anal Biochem. 2011; 416: 45-52
        • Robertson G.L.
        • Mahr E.A.
        • Athar S.
        • Sinha T.
        Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.
        J Clin Invest. 1973; 52: 2340-2352
        • Feldman R.
        • Gordon I.
        • Zagoory-Sharon O.
        Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: Considering stress and affiliation components of human bonding.
        Dev Sci. 2011; 14: 752-761
        • Zhong S.
        • Monakhov M.
        • Mok H.P.
        • Tong T.
        • Lai P.S.
        • Chew S.H.
        • et al.
        U-shaped relation between plasma oxytocin levels and behavior in the trust game.
        PloS One. 2012; 7: e51095
        • Rubin L.H.
        • Carter C.S.
        • Bishop J.R.
        • Pournajafi-Nazarloo H.
        • Drogos L.L.
        • Hill S.K.
        • et al.
        Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders.
        Schizophr Bull. 2014; 40: 1374-1384
        • Weisman O.
        • Zagoory-Sharon O.
        • Schneiderman I.
        • Gordon I.
        • Feldman R.
        Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety.
        Psychoneuroendocrinology. 2013; 38: 694-701
        • Jobst A.
        • Dehning S.
        • Ruf S.
        • Notz T.
        • Buchheim A.
        • Henning-Fast K.
        • et al.
        Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients.
        Acta Neuropsychiatr. 2014; 26: 347-355
        • Turan T.
        • Uysal C.
        • Asdemir A.
        • Kilic E.
        May oxytocin be a trait marker for bipolar disorder?.
        Psychoneuroendocrinology. 2013; 38: 2890-2896
        • Gordon I.
        • Zagoory-Sharon O.
        • Leckman J.F.
        • Feldman R.
        Oxytocin and the development of parenting in humans.
        Biol Psychiatry. 2010; 68: 377-382
        • McCullough M.E.
        • Churchland P.S.
        • Mendez A.J.
        Problems with measuring peripheral oxytocin: Can the data on oxytocin and human behavior be trusted?.
        Neurosci Biobehav Rev. 2013; 37: 1485-1492
      1. Assay Designs’ Oxytocin Enzyme Immunoassay (EIA) kit: Manufacturer’s instructions. Available at: http://www.enzolifesciences.com/fileadmin/redacteur/pdf/adi/ADI-900-153.pdf. Accessed May 25, 2015.

        • Christensen J.C.
        • Shiyanov P.A.
        • Estepp J.R.
        • Schlager J.J.
        Lack of association between human plasma oxytocin and interpersonal trust in a Prisoner’s Dilemma paradigm.
        PLoS One. 2014; 9: e116172
        • Robinson K.J.
        • Hazon N.
        • Lonergan M.
        • Pomeroy P.P.
        Validation of an enzyme-linked immunoassay (ELISA) for plasma oxytocin in a novel mammal species reveals potential errors induced by sampling procedure.
        J Neurosci Meth. 2014; 226: 73-79
        • Suraev A.S.
        • Bowen M.T.
        • Ali S.O.
        • Hicks C.
        • Ramos L.
        • McGregor I.S.
        Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood.
        Horm Behav. 2014; 65: 488-496
        • Szeto A.
        • McCabe P.M.
        • Nation D.A.
        • Tabak B.A.
        • Rossetti M.A.
        • McCullough M.E.
        • et al.
        Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin.
        Psychosom Med. 2011; 73: 393-400
        • Wismer Fries A.B.
        • Ziegler T.E.
        • Kurian J.R.
        • Jacoris S.
        • Pollak S.D.
        Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior.
        Proc Natl Acad Sci U S A. 2005; 102: 17237-17240
        • Anderson G.M.
        Report of altered urinary oxytocin and AVP excretion in neglected orphans should be reconsidered.
        J Autism Dev Disord. 2006; 36: 829-830
        • Young S.N.
        • Anderson G.N.
        Bioanalytical inaccuracy: A threat to the integrity and efficiency of research.
        J Psychiatry Neurosci. 2010; 35: 3-6
        • Seltzer L.J.
        • Ziegler T.E.
        • Pollak S.D.
        Social vocalizations can release oxytocin in humans.
        Proc Biol Sci. 2010; 277: 2661-2666
        • Knobloch H.S.
        • Charlet A.
        • Hoffmann L.C.
        • Eliava M.
        • Khrulev S.
        • Cetin A.H.
        • et al.
        Evoked axonal oxytocin release in the central amygdala attenuates fear response.
        Neuron. 2012; 73: 553-566
        • Sabatier N.
        • Leng G.
        • Menzies J.
        Oxytocin, feeding, and satiety.
        Front Endocrinol. 2013; 4: 35
        • Sabatier N.
        • Caquineau C.
        • Dayanithi G.
        • Bull P.
        • Douglas A.J.
        • Guan X.M.
        • et al.
        Alpha-melanocyte-stimulating hormone stimulates oxytocin release from the dendrites of hypothalamic neurons while inhibiting oxytocin release from their terminals in the neurohypophysis.
        J Neurosci. 2003; 23: 10351-10358
        • Neumann I.
        • Landgraf R.
        • Takahashi Y.
        • Pittman Q.J.
        • Russell J.A.
        Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8.
        Am J Physiol. 1994; 267: R1626-R1631
        • Brown D.C.
        • Perkowski S.Z.
        • Shofer F.
        • Amico J.A.
        Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs.
        Am J Vet Res. 2001; 62: 496-499
        • Kendrick K.M.
        • Keverne E.B.
        • Hinton M.R.
        • Goode J.A.
        Cerebrospinal fluid and plasma concentrations of oxytocin and vasopressin during parturition and vaginocervical stimulation in the sheep.
        Brain Res Bull. 1991; 26: 803-807
        • Wotjak C.T.
        • Ganster J.
        • Kohl G.
        • Holsboer F.
        • Landgraf R.
        • Engelmann M.
        Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: New insights into the secretory capacities of peptidergic neurons.
        Neuroscience. 1998; 85: 1209-1222
        • Ivanyi T.
        • Wiegant V.M.
        • de Wied D.
        Differential effects of emotional and physical stress on the central and peripheral secretion of neurohypophysial hormones in male rats.
        Life Sci. 1991; 48: 1309-1316
        • Moos F.
        • Poulain D.A.
        • Rodriguez F.
        • Guerne Y.
        • Vincent J.D.
        • Richard P.
        Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats.
        Exp Brain Res. 1989; 76: 593-602
        • Robinson I.C.
        • Jones P.M.
        Oxytocin and neurophysin in plasma and CSF during suckling in the guinea-pig.
        Neuroendocrinology. 1982; 34: 59-63
        • Amico J.A.
        • Challinor S.M.
        • Cameron J.L.
        Pattern of oxytocin concentrations in the plasma and cerebrospinal fluid of lactating rhesus monkeys (Macaca mulatta): evidence for functionally independent oxytocinergic pathways in primates.
        J Clin Endocrinol Metabol. 1990; 71: 1531-1535
        • Perlow M.J.
        • Reppert S.M.
        • Artman H.A.
        • Fisher D.A.
        • Self S.M.
        • Robinson A.G.
        Oxytocin, vasopressin, and estrogen-stimulated neurophysin: Daily patterns of concentration in cerebrospinal fluid.
        Science. 1982; 216: 1416-1418
        • Winslow J.T.
        • Noble P.L.
        • Lyons C.K.
        • Sterk S.M.
        • Insel T.R.
        Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys.
        Neuropsychopharmacology. 2003; 28: 910-918
        • Martin J.
        • Kagerbauer S.M.
        • Schuster T.
        • Blobner M.
        • Kochs E.F.
        • Landgraf R.
        Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage.
        Neuropeptides. 2014; 48: 91-96
        • Jokinen J.
        • Chatzittofis A.
        • Hellstrom C.
        • Nordstrom P.
        • Uvnas-Moberg K.
        • Asberg M.
        Low CSF oxytocin reflects high intent in suicide attempters.
        Psychoneuroendocrinology. 2012; 37: 482-490
        • Kagerbauer S.M.
        • Martin J.
        • Schuster T.
        • Blobner M.
        • Kochs E.F.
        • Landgraf R.
        Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.
        J Neuroendocrinol. 2013; 25: 668-673
        • Kuypers K.P.
        • de la Torre R.
        • Farre M.
        • Yubero-Lahoz S.
        • Dziobek I.
        • Van den Bos W.
        • et al.
        No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation.
        PloS One. 2014; 9: e100719
        • Carson D.S.
        • Berquist S.W.
        • Trujillo T.H.
        • Garner J.P.
        • Hannah S.L.
        • Hyde S.A.
        • et al.
        Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.
        Mol Psychiatry. 2015; 20: 1085-1090
        • Murphy M.R.
        • Seckl J.R.
        • Burton S.
        • Checkley S.A.
        • Lightman S.L.
        Changes in oxytocin and vasopressin secretion during sexual activity in men.
        J Clin Endocrinol Metab. 1987; 65: 738-741
        • Kruger T.H.
        • Schiffer B.
        • Eikermann M.
        • Haake P.
        • Gizewski E.
        • Schedlowski M.
        Serial neurochemical measurement of cerebrospinal fluid during the human sexual response cycle.
        Eur J Neurosci. 2006; 24: 3445-3452
        • Kosfeld M.
        • Heinrichs M.
        • Zak P.J.
        • Fischbacher U.
        • Fehr E.
        Oxytocin increases trust in humans.
        Nature. 2005; 435: 673-676
        • Conlisk J.
        Professor Zak’s empirical studies on trust and oxytocin.
        J Econ Behav Organ. 2011; 78: 160-166
        • Ioannidis J.P.
        Why most published research findings are false.
        PLoS Med. 2005; 2: e124
        • Ferguson C.J.
        • Heene M.
        A vast graveyard of undead theories: Publication bias and psychological science’s aversion to the null.
        Perspect Psychol Sci. 2012; 7: 555-561
        • John L.K.
        • Loewenstein G.
        • Prelec D.
        Measuring the prevalence of questionable research practices with incentives for truth telling.
        Psychol Sci. 2012; 23: 524-532
        • Simmons J.P.
        • Nelson L.D.
        • Simonsohn U.
        False-positive psychology: Undisclosed flexibility in data collection and analysis allows presenting anything as significant.
        Psychol Sci. 2011; 22: 1359-1366
        • Horta de Macedo L.R.
        • Zuardi A.W.
        • Machado-de-Sousa J.P.
        • Chagas M.H.
        • Hallak J.E.
        Oxytocin does not improve performance of patients with schizophrenia and healthy volunteers in a facial emotion matching task.
        Psychiatry Res. 2014; 220: 125-128
        • Woolley J.D.
        • Chuang B.
        • Lam O.
        • Lai W.
        • O’Donovan A.
        • Rankin K.P.
        • et al.
        Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
        Psychoneuroendocrinology. 2014; 47: 116-125
        • Cacciotti-Saija C.
        • Langdon R.
        • Ward P.B.
        • Hickie I.B.
        • Scott E.M.
        • Naismith S.L.
        • et al.
        A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.
        Schizophr Bull. 2015; 41: 483-493
        • Einfeld S.L.
        • Smith E.
        • McGregor I.S.
        • Steinbeck K.
        • Taffe J.
        • Rice L.J.
        • et al.
        A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome.
        Am J Med Genet A. 2014; 164A: 2232-2239
        • Dadds M.R.
        • MacDonald E.
        • Cauchi A.
        • Williams K.
        • Levy F.
        • Brennan J.
        Nasal oxytocin for social deficits in childhood autism: A randomized controlled trial.
        J Autism Dev Disord. 2014; 44: 521-531
        • Guastella A.J.
        • Gray K.M.
        • Rinehart N.J.
        • Alvares G.A.
        • Tonge B.J.
        • Hickie I.B.
        • et al.
        The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: A randomized controlled trial.
        J Child Psychol Psychiatry. 2014; 56: 444-452